2011Huanggang zhiye jishu xueyuan xuebaoRequires access

Cefoperazone/sulbactam in the treatment of respiratoryinfections 175 cases of clinical observation

Mei Yu-zhen

Open publisher page 0 citations

Abstract

Cefoperazone/sulbactam in the treatment of respiratory infections efficacy and safety.Methods: January 2006-December 2010 175 cases of cefoperazone/sulbactam in the treatment of respiratory infections were studied retrospectively to summarize the efficacy and toxicity.The results of cefoperazone/sulbactam dosage daily 2g ~ 4g,course of 5 to 18 days;3 to 6.5 days after treatment decreased body temperature,body temperature decreased rate of 92.0%;white blood cell count increased by 85.4% after treatment to normal range,52.6% of X-ray findings of inflammatory disappeared or significantly improved absorption,sputum bacterial culture positive bacterial clearance rate was 85.1%;total effective rate was 86.9%,ineffective in 12 cases of severe neutropenia;16 patients alanyl transient increase in acid transaminase,I was no other side effects.Conclusion: cefoperazone/sulbactam in the treatment of respiratory infections safety effect.

About this research paper

What this paper is about

Cefoperazone/sulbactam in the treatment of respiratory infections efficacy and safety.Methods: January 2006-December 2010 175 cases of cefoperazone/sulbactam in the treatment of respiratory infections were studied retrospectively to summarize the efficacy and toxicity.The results of cefoperazone/sulbactam dosage daily 2g ~ 4g,course of 5 to 18 days;3 to 6.5 days after treatment decreased body temperature,body temperature decreased rate of 92.0%;white blood cell count increased by 85.4% after treatment to normal range,52.6% of X-ray findings of inflammatory disappeared or significantly improved absorption,sputum bacterial culture positive bacterial clearance rate was 85.1%;total effective rate was 86.9%,ineffective in 12 cases of severe neutropenia;16 patients alanyl transient increase in acid transaminase,I was no other side effects.Conclusion: cefoperazone/sulbactam in the treatment of respiratory infections safety effect.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Cefoperazone/sulbactam in the treatment of respiratory infections efficacy and safety.Methods: January 2006-December 2010 175 cases of cefoperazone/sulbactam in the treatment of respiratory infections were studied retrospectively to summarize the efficacy and toxicity.The results of cefoperazone/sulbactam dosage daily 2g ~ 4g,course of 5 to 18 days;3 to 6.5 days after treatment decreased body temperature,body temperature decreased rate of 92.0%;white blood cell count increased by 85.4% after treatment to normal range,52.6% of X-ray findings of inflammatory disappeared or significantly improved absorption,sputum bacterial culture positive bacterial clearance rate was 85.1%;total effective rate was 86.9%,ineffective in 12 cases of severe neutropenia;16 patients alanyl transient increase in acid transaminase,I was no other side effects.Conclusion: cefoperazone/sulbactam in the treatment of respiratory infections safety effect.

Key concepts: Cefoperazone, Medicine, Sulbactam, Neutropenia, Gastroenterology, White blood cell, Sputum, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Cefoperazone/sulbactam in the treatment of respiratoryinfections 175 cases of clinical observation — Research Paper | ScholarLens